查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089120

次世代定序資料分析市場：2026-2032年全球市場預測（依產品類型、工作流程階段、定序方法、自動化程度、應用和最終用戶分類）

Next-Generation Sequencing Data Analysis Market by Product Type, Workflow Stage, Sequencing Type, Automation Level, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，次世代定序資料分析市場將成長至 24.6 億美元，複合年成長率為 12.06%。

主要市場統計數據
基準年 2025 11.1億美元
預計年份：2026年 12.4億美元
預測年份 2032 24.6億美元
複合年成長率 (%) 12.06%

次世代定序（NGS）資料分析已成為精準醫療、臨床診斷、藥物研發、群體基因體學和轉化研究等領域的主要成長引擎。自人類基因組計畫早期以來，定序成本大幅下降，產業的瓶頸已從序列讀取轉移到基因組數據的大規模管理、比對、註釋、解讀、安全和實用化。

需求最高的領域是那些需要可靠的NGS生物資訊學流程、可重複的變異檢測、合規的雲端基礎設施以及臨床有效的解讀的機構。經營團隊目前的優先事項集中在縮短處理時間、提高分析準確性、增強數據互通性以及將基因組證據與電子健康記錄、真實世界數據和多體學資料集連接起來的能力。

NGS資料分析前景的變革性變化

NGS數據分析的格局正在重塑，其工作流程正從僅用於研究轉向受監管的臨床和企業級環境。檢查室正在標準化品管、比對、變異檢測、拷貝數分析、結構變異檢測和註釋等流程，而醫療系統則面臨著對審計追蹤、工作流程檢驗和安全資料交換日益成長的需求。

人工智慧對NGS分析的累積影響

人工智慧透過最佳化鹼基辨識、序列比對、變異優先排序、表現型匹配和結果解讀等工作流程，顯著提升了NGS數據分析的效率。深度學習工具在識別小規模變異方面表現出色，而人工智慧驅動的註釋功能則有助於減輕臨床檢查室和研究團隊的人工審核負擔。

全球NGS數據分析市場的關鍵區域洞察

北美憑藉其成熟的定序基礎設施、臨床基因組學的高普及率、完善的雲端生態系以及來自醫療系統、學術機構和生命科學組織的大規模投資，仍然是新一代測序（NGS）數據分析的領先地區。美國透過臨床腫瘤學、罕見疾病診斷、公共衛生基因組學和規範的檢查室工作流程來支持區域需求，而加拿大則透過人口健康舉措、學術基因組學網路以及公共衛生領域的定序能力做出貢獻。

關於NGS資料分析實施的關鍵群體特定見解

歐盟正透過協調研究經費、努力利用跨境健康數據、符合GDPR的隱私要求以及促進成員國之間安全共用基因組數據的舉措，塑造著新一代測序（NGS）數據分析的格局。七國集團（G7）在臨床級基因組學、人工智慧管治、藥物研發整合、公共衛生定序和基於標準的數據基礎設施方面處於主導，而北約成員國也日益認知到病原體基因組學、生物安全分析和彈性健康數據系統是其戰略能力。

主要國家次世代定序資料分析的發展趨勢

美國在臨床基因組學、腫瘤檢測、雲生物資訊學、公共衛生定序以及符合監管要求的檢驗有效性方面處於主導，而加拿大則專注於研究網路、公共衛生基因組學、原住民和人群健康考量以及公平獲取。墨西哥和巴西正在透過區域檢查室現代化和在大學附屬醫療中心實施相關技術，增強其在腫瘤學、感染疾病、生殖健康、罕見疾病研究和農業基因組學領域的新一代定序（NGS）能力。

針對NGS數據分析領域領導者的實用建議

產業領導者應優先考慮檢驗的模組化NGS生物資訊流程，這些流程能夠處理短讀長、長讀長、單細胞、空間、元基因組、液態生物檢體和多組體學工作流程。投資應著重於與實驗室資訊管理系統、電子健康記錄、精心整理的知識庫、安全雲端環境和標準化資料交換框架的互通性。

檢驗的NGS情報調查方法

本執行摘要基於一套系統的調查方法，該方法結合了二手資料研究、市場情報、技術趨勢評估、監管審查和行業檢驗。資訊來源包括公共衛生機構、國家基因組計畫資訊披露、同儕審查文獻、監管指南、臨床實踐趨勢、技術文件、標準化機構和專家意見。

結論：NGS資料分析的未來

次世代定序(NGS) 資料分析的下一階段將由臨床效用、人工智慧驅動的解讀、雲端擴充性和安全的基因組資料交換的融合所定義。隨著定序日益融入常規醫療保健，能夠提供可靠結果、提高工作流程效率、增強可重複性和符合監管要求的分析服務提供者將在整個價值鏈中變得越來越重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章次世代定序資料分析市場：依產品類型分類

  • 服務
    • 數據分析服務
    • 生物資訊諮詢服務
    • 基於雲端的分析服務
  • 軟體

第8章次世代定序資料分析市場：依工作流程階段分類

  • 初步分析
    • 基地識別
    • 訊號處理
    • 連接複用解復用
  • 二次分析
    • 讀取映射
    • 數組對齊
    • 變體調用
      • SNP檢測
      • 插入缺失檢測
  • 三級分析
    • 變異註釋
    • 功能分析
    • 訊號傳導通路分析

第9章次世代定序資料分析市場：依定定序類型分類

  • 全基因測序
  • 全EXOME定序
  • 標靶定序
  • RNA定序
  • 表觀基因定序

第10章：次世代定序資料分析市場：依自動化程度分類

  • 人工分析
  • 半自動分析
  • 全自動分析

第11章次世代定序資料分析市場：按應用領域分類

  • 臨床診斷
    • 腫瘤學
    • 罕見疾病
    • 感染疾病
    • 生殖健康
    • 基因篩檢
  • 藥物發現與開發
    • 目標識別
    • 生物標記發現
    • 藥物基因體學
  • 農業和畜牧業調查
  • 法醫學基因組學

第12章次世代定序資料分析市場：依最終用戶分類

  • 學術研究機構
  • 政府與公共衛生實驗室
  • 合約研究組織（CRO）
  • 醫院和診所
  • 製藥和生物技術公司

第13章次世代定序資料分析市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章次世代定序資料分析市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章次世代定序資料分析市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • 10x Genomics Inc
  • Agilent Technologies Inc
  • Basepair Inc
  • BGI Group
  • Bio-Rad Laboratories Inc
  • DNAnexus Inc
  • DNASTAR Inc
  • Element Biosciences Inc
  • Fabric Genomics Inc
  • Genscript Biotech Corp
  • Golden Helix Inc
  • Illumina Inc
  • MedGenome Inc
  • MGI Tech Co Ltd
  • Novogene Co Ltd
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc
  • Psomagen Inc
  • QIAGEN
  • Revvity Inc
  • SOPHiA GENETICS SA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience Corp
Product Code: MRR-EC2E133E33B2

The Next-Generation Sequencing Data Analysis Market is projected to grow by USD 2.46 billion at a CAGR of 12.06% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.11 billion
Estimated Year [2026] USD 1.24 billion
Forecast Year [2032] USD 2.46 billion
CAGR (%) 12.06%

Next-generation sequencing data analysis has become a core growth engine for precision medicine, clinical diagnostics, pharmaceutical discovery, population genomics, and translational research. As sequencing costs have declined dramatically since the early Human Genome Project era, the industry bottleneck has shifted from generating reads to managing, aligning, annotating, interpreting, securing, and operationalizing genomic data at scale.

Demand is strongest where organizations need reliable NGS bioinformatics pipelines, reproducible variant calling, compliant cloud infrastructure, and clinically defensible interpretation. Executive priorities now center on faster turnaround times, higher analytical accuracy, data interoperability, and the ability to connect genomic evidence with electronic health records, real-world evidence, and multi-omics datasets.

Transformative Shifts in the NGS Data Analysis Landscape

The NGS data analysis landscape is being reshaped by the migration from research-only workflows to regulated clinical and enterprise-grade environments. Laboratories are standardizing pipelines around quality control, alignment, variant calling, copy number analysis, structural variant detection, and annotation, while healthcare systems increasingly require audit trails, workflow validation, and secure data exchange.

Cloud bioinformatics, workflow orchestration, containerization, and open data standards are accelerating scalability and reproducibility. At the same time, long-read sequencing, single-cell sequencing, spatial genomics, liquid biopsy, and metagenomics are expanding analytical complexity. These shifts are increasing demand for platforms that can process diverse data types without compromising accuracy, compliance, or cost efficiency.

Cumulative Impact of Artificial Intelligence on NGS Analytics

Artificial intelligence is materially improving NGS data analysis by enhancing base calling, read mapping support, variant prioritization, phenotype matching, and interpretation workflows. Deep learning tools have demonstrated strong performance in small-variant calling, while AI-assisted annotation helps reduce manual review burden for clinical laboratories and research teams.

The cumulative impact of AI is not limited to speed. Machine learning enables pattern recognition across large genomic and multi-omics datasets, supporting oncology biomarker discovery, rare disease diagnosis, pharmacogenomics, infectious disease surveillance, and patient stratification. However, adoption depends on explainability, bias control, validation, cybersecurity, and alignment with regulatory expectations for clinical decision support.

Key Regional Insights Across Global NGS Data Analysis Markets

North America remains a leading region for NGS data analysis because of mature sequencing infrastructure, strong clinical genomics adoption, established cloud ecosystems, and major investments from health systems, academic centers, and life sciences organizations. The United States anchors regional demand through clinical oncology, rare disease diagnostics, public health genomics, and regulated laboratory workflows, while Canada contributes through population health initiatives, academic genomics networks, and public health sequencing capacity.

Europe is driven by national genomics programs, GDPR-governed data frameworks, and strong adoption in oncology, rare disease, reproductive health, and public health sequencing. Asia-Pacific is expanding as China, Japan, India, South Korea, Australia, and ASEAN markets invest in precision medicine, biobanks, hospital-based sequencing, and infectious disease genomics. Latin America shows rising demand in Brazil and Mexico as laboratories modernize oncology, pathogen surveillance, and agricultural genomics capabilities. The Middle East is building capacity through national genome initiatives, digital health modernization, and hereditary disease programs, while Africa is strengthening NGS data analysis through pathogen genomics networks, antimicrobial resistance monitoring, tuberculosis and malaria surveillance, and growing academic genomics collaborations.

Key Group Insights for NGS Data Analysis Adoption

The European Union is shaping NGS data analysis through coordinated research funding, cross-border health data ambitions, GDPR-aligned privacy requirements, and efforts to enable secure genomic data sharing across member states. G7 countries lead in clinical-grade genomics, AI governance, pharmaceutical R&D integration, public health sequencing, and standards-based data infrastructure, while NATO members increasingly recognize pathogen genomics, biosecurity analytics, and resilient health data systems as strategic capabilities.

BRICS markets are expanding sequencing capacity through population-scale research, domestic biotechnology investment, infectious disease monitoring, agricultural genomics, and growing clinical demand. ASEAN countries are adopting NGS in infectious disease surveillance, oncology, newborn screening, and academic research at varying levels of infrastructure maturity, creating demand for scalable and cost-efficient bioinformatics. The GCC is investing in national genome programs, digital health platforms, and precision medicine initiatives, creating demand for secure, scalable, and culturally representative genomic data analysis systems that support both clinical and population health use cases.

Key Country Insights in Next-Generation Sequencing Data Analysis

The United States leads in clinical genomics, oncology testing, cloud bioinformatics, public health sequencing, and regulatory-aware analytical validation, while Canada emphasizes research networks, public health genomics, indigenous and population health considerations, and equitable access. Mexico and Brazil are building stronger NGS capabilities for oncology, infectious disease, reproductive health, rare disease research, and agricultural genomics, supported by regional laboratory modernization and academic medical center adoption.

In Europe, the United Kingdom benefits from national genomic medicine infrastructure and health-system-linked sequencing, Germany and France invest heavily in precision medicine, clinical research, and translational genomics, Italy and Spain expand oncology and rare disease testing, and Russia maintains academic, agricultural, and public health sequencing capacity. China is a major sequencing and bioinformatics hub with extensive population genomics, oncology, and infectious disease capabilities. India is scaling cost-efficient genomics, diagnostics, newborn screening, and pathogen surveillance, while Japan focuses on precision oncology, pharmacogenomics, and aging-related research. Australia supports national genomic medicine initiatives, rare disease programs, and public health sequencing, and South Korea advances hospital-based genomics, biobanking, precision oncology, and AI-enabled healthcare analytics.

Actionable Recommendations for NGS Data Analysis Leaders

Industry leaders should prioritize validated, modular NGS bioinformatics pipelines that can support short-read, long-read, single-cell, spatial, metagenomic, liquid biopsy, and multi-omics workflows. Investment should focus on interoperability with laboratory information management systems, electronic health records, curated knowledge bases, secure cloud environments, and standardized data exchange frameworks.

Organizations should also strengthen data governance, model validation, cyber resilience, quality management, and compliance readiness. Strategic differentiation will come from reducing turnaround time, improving variant interpretation quality, expanding ancestry-aware reference datasets, supporting reproducible workflows, and building partnerships with hospitals, biopharma organizations, public health agencies, and academic genome centers.

Research Methodology for Verified NGS Intelligence

This executive summary is built on a structured research methodology combining secondary research, market intelligence, technology trend assessment, regulatory review, and industry validation. Sources typically include public health agencies, national genomics program disclosures, peer-reviewed literature, regulatory guidance, clinical practice developments, technical documentation, standards organizations, and expert perspectives.

Insights are triangulated across demand indicators, technology adoption patterns, regional policy environments, funding signals, infrastructure readiness, and end-user workflows. The methodology emphasizes verifiable evidence, consistency checks, and practical relevance for decision-makers evaluating NGS data analysis platforms, services, infrastructure, and partnerships, while avoiding unverified sizing or forecasting claims.

Conclusion: The Future of NGS Data Analysis

The next phase of next-generation sequencing data analysis will be defined by the convergence of clinical utility, AI-enabled interpretation, cloud scalability, and secure genomic data exchange. As sequencing becomes more embedded in routine healthcare, the value chain will increasingly reward analytics providers that deliver trusted results, workflow efficiency, reproducibility, and regulatory confidence.

Organizations that align bioinformatics innovation with clinical evidence, privacy protection, ancestry-aware interpretation, and global interoperability will be best positioned to capture opportunities across precision medicine, oncology, rare disease diagnostics, public health surveillance, infectious disease monitoring, pharmacogenomics, and multi-omics research worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Next-Generation Sequencing Data Analysis Market, by Product Type

  • 7.1. Services
    • 7.1.1. Data Analysis Services
    • 7.1.2. Bioinformatics Consulting Services
    • 7.1.3. Cloud-based Analysis Services
  • 7.2. Software

8. Next-Generation Sequencing Data Analysis Market, by Workflow Stage

  • 8.1. Primary Analysis
    • 8.1.1. Base Calling
    • 8.1.2. Signal Processing
    • 8.1.3. Demultiplexing
  • 8.2. Secondary Analysis
    • 8.2.1. Read Mapping
    • 8.2.2. Sequence Alignment
    • 8.2.3. Variant Calling
      • 8.2.3.1. SNP Detection
      • 8.2.3.2. Indel Detection
  • 8.3. Tertiary Analysis
    • 8.3.1. Variant Annotation
    • 8.3.2. Functional Analysis
    • 8.3.3. Pathway Analysis

9. Next-Generation Sequencing Data Analysis Market, by Sequencing Type

  • 9.1. Whole Genome Sequencing
  • 9.2. Whole Exome Sequencing
  • 9.3. Targeted Sequencing
  • 9.4. RNA Sequencing
  • 9.5. Epigenomic Sequencing

10. Next-Generation Sequencing Data Analysis Market, by Automation Level

  • 10.1. Manual Analysis
  • 10.2. Semi-automated Analysis
  • 10.3. Fully Automated Analysis

11. Next-Generation Sequencing Data Analysis Market, by Application

  • 11.1. Clinical Diagnostics
    • 11.1.1. Oncology
    • 11.1.2. Rare Diseases
    • 11.1.3. Infectious Diseases
    • 11.1.4. Reproductive Health
    • 11.1.5. Genetic Screening
  • 11.2. Drug Discovery & Development
    • 11.2.1. Target Identification
    • 11.2.2. Biomarker Discovery
    • 11.2.3. Pharmacogenomics
  • 11.3. Agriculture & Animal Research
  • 11.4. Forensic Genomics

12. Next-Generation Sequencing Data Analysis Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Government & Public Health Laboratories
  • 12.3. Contract Research Organization
  • 12.4. Hospitals & Clinics
  • 12.5. Pharmaceutical & Biotechnology Companies

13. Next-Generation Sequencing Data Analysis Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Next-Generation Sequencing Data Analysis Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Next-Generation Sequencing Data Analysis Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. 10x Genomics Inc
  • 17.2. Agilent Technologies Inc
  • 17.3. Basepair Inc
  • 17.4. BGI Group
  • 17.5. Bio-Rad Laboratories Inc
  • 17.6. DNAnexus Inc
  • 17.7. DNASTAR Inc
  • 17.8. Element Biosciences Inc
  • 17.9. Fabric Genomics Inc
  • 17.10. Genscript Biotech Corp
  • 17.11. Golden Helix Inc
  • 17.12. Illumina Inc
  • 17.13. MedGenome Inc
  • 17.14. MGI Tech Co Ltd
  • 17.15. Novogene Co Ltd
  • 17.16. Oxford Nanopore Technologies PLC
  • 17.17. Pacific Biosciences of California Inc
  • 17.18. Psomagen Inc
  • 17.19. QIAGEN
  • 17.20. Revvity Inc
  • 17.21. SOPHiA GENETICS SA
  • 17.22. Takara Bio Inc
  • 17.23. Thermo Fisher Scientific Inc
  • 17.24. Twist Bioscience Corp

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DATA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOINFORMATICS CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOINFORMATICS CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOINFORMATICS CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CLOUD-BASED ANALYSIS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CLOUD-BASED ANALYSIS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CLOUD-BASED ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PRIMARY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PRIMARY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PRIMARY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BASE CALLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BASE CALLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BASE CALLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SIGNAL PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SIGNAL PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SIGNAL PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DEMULTIPLEXING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DEMULTIPLEXING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DEMULTIPLEXING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SECONDARY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SECONDARY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SECONDARY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL READ MAPPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL READ MAPPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL READ MAPPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEQUENCE ALIGNMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SEQUENCE ALIGNMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEQUENCE ALIGNMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VARIANT CALLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VARIANT CALLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VARIANT CALLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SNP DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SNP DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SNP DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INDEL DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INDEL DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INDEL DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TERTIARY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TERTIARY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TERTIARY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VARIANT ANNOTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VARIANT ANNOTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VARIANT ANNOTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FUNCTIONAL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FUNCTIONAL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FUNCTIONAL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PATHWAY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PATHWAY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PATHWAY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WHOLE EXOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL EPIGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL EPIGENOMIC SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL EPIGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MANUAL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MANUAL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MANUAL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SEMI-AUTOMATED ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SEMI-AUTOMATED ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SEMI-AUTOMATED ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FULLY AUTOMATED ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FULLY AUTOMATED ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FULLY AUTOMATED ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RARE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RARE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RARE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GENETIC SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GENETIC SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GENETIC SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GOVERNMENT & PUBLIC HEALTH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GOVERNMENT & PUBLIC HEALTH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL GOVERNMENT & PUBLIC HEALTH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 244. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 246. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 247. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 250. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 253. GCC NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 287. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 288. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 289. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 292. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 295. G7 NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 299. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 300. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 301. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY VARIANT CALLING, 2018-2032 (USD MILLION)
  • TABLE 303. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY TERTIARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SEQUENCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 306. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 308. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 309. NATO NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY PRIMARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE, BY SECONDARY ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES NEXT